DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Ester Baiget - 4 Novozymes - 3 Lukas Schulze - 1 Baiget - 1 Steve Sedgwick - 1 Ilham Kadri - 1 Kadri - 1 Hansen - 1
Top related locs:
Europe Germany Switzerland Danish Asia Denmark Bergheim Davos
Top related orgs:
CNBC - 3 U.S - 2 Nokia - 2 Getty - 1 Economic - 1 Chr - 1 Danish bioscience - 1 WS Audiology - 1

Search resuls for: "Novozymes"


13 mentions found


☆ Top business leaders bemoan archaic systems in Europe that are curbing climate solutions
  + stars: | 2024-01-26 | by ( Vicky Mckeever | ) www.cnbc.com   time to read: +2 min
Ester Baiget, the CEO of biosolutions firm Novozymes, said that "roadblocks" usually stand in the way of companies producing sustainable solutions which needed to be removed. watch nowMicrobes have been put forward as an alternative to reduce the use of chemical fertilizers, which contribute to greenhouse gas emissions. However, new microbial fertilizers need to go through regulatory approval before going to market. We need to rethink regulation in regions like Europe." Kadri also said there was a "lack of competitiveness in Europe," referring to the difficulties faced by her sector.
Persons: Lukas Schulze, Ester Baiget, Novozymes, Baiget, Steve Sedgwick, Ilham Kadri, Kadri Organizations: Getty, CNBC, Economic Locations: Bergheim, Germany, Davos, Switzerland, Europe
☆ We have a regulation that is based on the passed: Novozymes CEO
  + stars: | 2024-01-25 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe have a regulation that is based on the passed: Novozymes CEO"We have a regulation which is based on the past," Ester Baiget, the CEO of biosolutions firm Novozymes, told CNBC, pointing out that in her own sector it can take six years to register a new microbe (or microorganism) to replace fertilizers.
Persons: Ester Baiget, Novozymes Organizations: CNBC
☆ Novozymes CEO is confident its merger with Chr. Hansen will close in Q1
  + stars: | 2024-01-17 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNovozymes CEO is confident its merger with Chr. Hansen will close in Q1Novozymes CEO Ester Baiget discusses the Danish biotechnology company's planned combination with with fellow biotech firm Chr.
Persons: Hansen, Ester Baiget Organizations: Chr Locations: Danish
☆ Pleo appoints new CFO as it looks to get in shape for IPO
  + stars: | 2023-12-13 | by ( Ryan Browne | ) www.cnbc.com   time to read: +2 min
Danish fintech firm Pleo has appointed a new chief financial officer, the company told CNBC exclusively, beefing up its executive team — a sign the company is readying itself for an eventual initial public offering. Most notably, Lonning had experience as CFO at Danish food enzyme maker Chr Hansen. Chr Hansen, which is listed on the Danish stock exchange, is one of Denmark's most valuable publicly listed firms, with a market cap of more than $10 billion. The European Union recently approved a $22 billion merger between Chr Hansen and competitor Novozymes. That's a dilemma for companies, but even more so for the lifestyle of Pleo and tech companies."
Persons: Pleo, Soren Westh Lonning, Chr Hansen, Lonning, Novozymes Organizations: CNBC, Danish bioscience, WS Audiology, Danish, European Union
☆ Regulation is still a 'roadblock' on the 'path to carbon neutrality,' Novozymes CEO says
  + stars: | 2023-12-01 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRegulation is still a 'roadblock' on the 'path to carbon neutrality,' Novozymes CEO saysEster Baiget, CEO of Novozymes, discusses progress toward climate goals and carbon neutrality, saying companies are still dealing with "roadblocks" including "regulation which is based on the past."
Persons: Ester Baiget
☆ European stocks open lower as earnings roll in; Standard Chartered plunges 10%; ECB set to hold rates
  + stars: | 2023-10-26 | by ( Jenni Reid | ) www.cnbc.com   time to read: +1 min
Auto stocks plunged 3.45% as results disappointed, while travel stocks traded 1.7% lower. European stock markets opened sharply lower Thursday as attention remains on third-quarter earnings and government bond yields. Results are out from a slew of companies including Standard Chartered, BNP Paribas, TotalEnergies, Volvo Cars, Novozymes, Volkswagen, Carrefour, Saab and Wacker Chemie. Meanwhile, monetary policy decisions are due from the European Central Bank — for which markets have priced in a more than 98% likelihood of a hold in interest rates — and the central bank of Turkey, from which economists polled by Reuters anticipate a 500 basis point hike to 35%. The benchmark 10-year Japanese government bond yield hit a fresh 10-year high ahead of a central bank meeting next week, according to Reuters data.
Organizations: Chartered, Standard Chartered, BNP, TotalEnergies, Volvo, Volkswagen, Carrefour, Saab, Wacker Chemie, Investors, Facebook, Meta, European Central Bank —, Reuters, Treasury Locations: London, Turkey, Asia, Pacific
☆ Novo Nordisk's Wegovy bonanza looms large in Denmark
  + stars: | 2023-10-05 | by ( Maggie Fick | ) www.reuters.com   time to read: +6 min
COPENHAGEN, Oct 5 (Reuters) - The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for its developer, Novo Nordisk (NOVOb.CO), but also for its home country of Denmark. Interviews with Danish economists, analysts, and executives at the Novo Nordisk Foundation which controls Novo highlight the benefits to the economy from jobs to private wealth - but also the potential pitfalls of relying on a single, outsized company. Record profits for Novo are projected to generate returns for the Foundation of more than $12 billion in coming years. Novo Nordisk added 3,500 jobs in Denmark in 2022, bringing the total in the country to 21,000 employees, out of 59,000 worldwide, a company spokesperson said. Before Wegovy, "we used to be kind of, 'Isn't Denmark the place where Stockholm is the capital?'"
Persons: Danes, Lars Skovgaard Andersen, Lars Christensen, Wegovy, Mads Krogsgaard Thomsen, " Thomsen, Moller, Thomsen, Melinda Gates, Rasmus Kristian Feldthusen, Maggie Fick, Jacob Gronholt, Alexander Smith, Josephine Mason, Michele Gershberg, Catherine Evans Organizations: Novo Nordisk, Novo Nordisk Foundation, Danske Bank, Copenhagen Business School, Novo, Foundation, Reuters, Novo Holdings, Carlsberg, Maersk, U.S, Melinda Gates Foundation, UK's Wellcome Trust, Wegovy, University of Copenhagen, Nokia, Pedersen, Thomson Locations: COPENHAGEN, Denmark, Stockholm, Copenhagen, Danish, Novo, Europe, North America, Asia, OUTGROWING DENMARK, Finland
☆ BofA reveals the global stocks that tend to outperform when the U.S. dollar rises
  + stars: | 2023-09-29 | by ( Amala Balakrishner | ) www.cnbc.com   time to read: +1 min
The U.S. dollar index hit its highest level since March earlier this month, while its 50-day moving average is showing signs of surpassing its 200-day counterpart. European stocks to benefit Bank of America's screen captures European companies that would "tend to outperform" when the U.S. dollar index rises. They also had a "significant and positive slope from regression [against] the U.S. dollar index." "Over the past five years, Low Risk stocks, Energy and Norway have tended to outperform the most when the DXY index has been rising," she added. Elsewhere Dutch media house Wolters Kluwer , Italian energy player Tenaris and Finnish telecommunication services provider Nokia also appeared on the screen.
Persons: BofA's Paulina Strzelinska, Strzelinska, Wolters, — CNBC's Michael Bloom Organizations: U.S, Bank of America, The U.S, Bank, Energy, Bank of, Tobacco, Diageo, BP, Bayer, Roche, Wolters Kluwer, Nokia Locations: The, Europe, Norway, Novozymes, Denmark, Qiagen, Germany, Switzerland
☆ Portfolio diversity means growth witnessed despite recessionary pressures, says Novozymes CEO
  + stars: | 2023-04-26 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailPortfolio diversity means growth witnessed despite recessionary pressures, says Novozymes CEOEster Baiget, CEO at Novozymes, discusses earnings, and explains the impacts of current macroeconomic conditions on the business.
☆ Enzyme makers Novozymes and Chr. Hansen to merge
  + stars: | 2022-12-12 | by ( ) www.reuters.com   time to read: +2 min
Copenhagen, Dec 12 (Reuters) - Danish food ingredients and enzymes makers Novozymes (NZYMb.CO) and Chr. While both companies' main business is producing enzymes, Chr. Following an extended opening auction at the Copenhagen blue chip index on Monday morning, shares in Novozymes dropped 7.5%, while Chr. Hansen shares jumped more than 33%. Hansen will receive 1.53 new shares in Novozymes, each nominally worth 2 Danish crowns ($0.2830), for every share in Chr.
☆ Bioscience firms Novozymes and Chr. Hansen to merge in biggest-ever Danish deal
  + stars: | 2022-12-12 | by ( Elliot Smith | ) www.cnbc.com   time to read: +1 min
Biotechnology firms Novozymes and Chr. Hansen agreed to combine in what will be the biggest-ever merger between two Danish companies. The new biosolutions group will have annual revenues of approximately 3.5 billion euros ($3.7 billion), the companies said. "Novozymes and Chr. Combining the two companies will create a global leader in biosolutions," Novo Holdings Chairman Lars Rebien Sørensen said.
☆ Novozymes is set to merge with Chr. Hansen as part of a historic deal
  + stars: | 2022-12-12 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNovozymes is set to merge with Chr. Hansen as part of a historic dealEster Baiget, CEO of Novozymes, discusses the planned merger of bioscience firms Novozymes and Chr.
☆ COP27: The private sector needs to step up, says Novozymes CEO
  + stars: | 2022-11-11 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCOP27: The private sector needs to step up, says Novozymes CEOEster Baiget, Novozymes CEO, says there needs to be more dialogue.
0 next >>
Total: 13